Drug assistance programs for insured patients? A conversation with AccessMED
Posted Oct 25 2010 4:46am
Pharmaceutical companies have always provided patient assistance programs for the uninsured. But as health care costs rise and patients are subjected to more cost-sharing, pharmaceutical companies are finding the pool of needy patients is growing. AccessMED, a US Oncology subsidiary that provides patient access and drug reimbursement solutions to the pharmaceutical industry, hosted a Patient Access Summit last month to explore health care reform’s impact on patient access and discuss other hot topics such as REMS .
In this podcast interview, AccessMED’s Scott Dulitz and Rick Ford discuss key themes emerging from the Summit and answered a variety of questions about patient access issues for expensive drugs.